Ryuji Takeda

Dr. Ryuji Takeda

Faculty of Health Sciences for Welfare, Kansai University of Welfare Sciences, Kashiwara-shi, Japan
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in Complementary Therapies in Medicine
Verified
Journal Article
Closed access
NUNaofumi Umigai
Naofumi Umigai
RTRyuji Takeda
Ryuji Takeda
AMAtsuko Mori
Atsuko Mori

1 July 2013 in Phytomedicine
Verified
Journal Article
Closed access
RTRyuji Takeda
Ryuji Takeda
TKTaisuke Koike
Taisuke Koike
ITItaru Taniguchi
Itaru Taniguchi
KTKeiko Tanaka
Keiko Tanaka

25 November 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
MYMaya Yamashita
Maya Yamashita
MMMasaya Miyoshi
Masaya Miyoshi
MIMasayuki Iwai
Masayuki Iwai
RTRyuji Takeda
Ryuji Takeda
TOTakahiro Ono
Takahiro Ono
TKToshihide Kabuki
Toshihide Kabuki
This article examines the effects of fermented milk (FM) containing Lactobacillus helveticus SBT2171 (LH2171) on the subjective symptoms of individuals with mild and moderate perennial allergy. Two hundred subjects were divided into two groups and consumed FM containing LH2171 or placebo FM once per day for 16 weeks. The primary endpoints were defined as per the degree of nasal and ocular symptoms and difficulty in daily life as determined by the Japanese guidelines for allergy rhinitis and the Japanese allergic rhinitis standard quality of life questionnaire, respectively. The secondary endpoints included parameters related to allergic symptoms in the blood and nasal fluids, as well as the mental status. The severity of allergic rhinitis significantly improved in the LH2171 group compared to that in the placebo group. Additionally, the LH2171 group showed a significantly lower degree of “stuffy nose” (as per the diary survey) than the placebo group. Eosinophil counts in the nasal fluids and in the blood were significantly lower in the LH2171 group compared to the placebo group. Thus, the oral administration of FM containing LH2171 cells alleviated perennial allergic rhinitis in individuals with mild and moderate symptoms, possibly via suppression of eosinophils in both the blood and nasal fluids.

1 November 2003 in Neuroscience Letters
Verified
Journal Article
Closed access
AHAkira Haji
Akira Haji
HYHiromi Yamazaki
Hiromi Yamazaki
YOYoshiaki Ohi
Yoshiaki Ohi
RTRyuji Takeda
Ryuji Takeda

12 January 2018 in International Ophthalmology
Verified
Journal Article
Closed access
PDF file
TTToyoaki Tsumura
Toyoaki Tsumura
KENJI KASHIWAGIKENJI KASHIWAGI
KENJI KASHIWAGI
YSYasuyuki Suzuki
Yasuyuki Suzuki
KYKeiji Yoshikawa
Keiji Yoshikawa
HSHirotaka Suzumura
Hirotaka Suzumura
MAMakoto Araie
Makoto Araie

17 March 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
KYKeisuke Yoshida
Keisuke Yoshida
OSOsamu Sakai
Osamu Sakai
THTomoo Honda
Tomoo Honda
TKTomio Kikuya
Tomio Kikuya
RTRyuji Takeda
Ryuji Takeda
CKChieko Koike
Chieko Koike
(1) Background: The impairment of eye–hand coordination and smooth-pursuit eye movement caused by visual display terminal (VDT) operation is thought to impair daily living activities, for which no effective methods are currently known. On the other hand, various food ingredients, including astaxanthin, lutein, and zeaxanthin, are known to help improve the eye health of VDT operators. This study aimed to test the hypothesis that the combination of astaxanthin, lutein, and zeaxanthin can prevent the impairment of eye–hand coordination and smooth-pursuit eye movement caused by VDT operation. (2) Methods: We conducted a randomized, placebo-controlled, parallel-group clinical trial. Healthy subjects who regularly worked with VDTs were randomly assigned to the active and placebo groups. All of the subjects took soft capsules containing 6 mg of astaxanthin, 10 mg of lutein, and 2 mg of zeaxanthin or placebo soft capsules once daily for eight weeks. We evaluated the eye–hand coordination, smooth-pursuit eye movements, and macular pigment optical density (MPOD) at 0, two, four, and eight weeks after soft-capsule intake. (3) Results: The active group showed significantly improved eye–hand coordination after VDT operation at eight weeks. However, there was no clear improvement in the effect of the supplementation on smooth-pursuit eye movements. The active group also showed a significant increase in MPOD levels. (4) Conclusions: Consumption of a supplement containing astaxanthin, lutein, and zeaxanthin mitigates the decline of eye–hand coordination after VDT operation.